2qsy
From Proteopedia
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
- | The eukaryotic nicotinamide riboside kinase (Nrk) pathway, which is | + | The eukaryotic nicotinamide riboside kinase (Nrk) pathway, which is induced in response to nerve damage and promotes replicative life span in yeast, converts nicotinamide riboside to nicotinamide adenine dinucleotide (NAD+) by phosphorylation and adenylylation. Crystal structures of human Nrk1 bound to nucleoside and nucleotide substrates and products revealed an enzyme structurally similar to Rossmann fold metabolite kinases and allowed the identification of active site residues, which were shown to be essential for human Nrk1 and Nrk2 activity in vivo. Although the structures account for the 500-fold discrimination between nicotinamide riboside and pyrimidine nucleosides, no enzyme feature was identified to recognize the distinctive carboxamide group of nicotinamide riboside. Indeed, nicotinic acid riboside is a specific substrate of human Nrk enzymes and is utilized in yeast in a novel biosynthetic pathway that depends on Nrk and NAD+ synthetase. Additionally, nicotinic acid riboside is utilized in vivo by Urh1, Pnp1, and Preiss-Handler salvage. Thus, crystal structures of Nrk1 led to the identification of new pathways to NAD+. |
==About this Structure== | ==About this Structure== | ||
Line 10: | Line 10: | ||
==Reference== | ==Reference== | ||
- | Nicotinamide | + | Nicotinamide riboside kinase structures reveal new pathways to NAD+., Tempel W, Rabeh WM, Bogan KL, Belenky P, Wojcik M, Seidle HF, Nedyalkova L, Yang T, Sauve AA, Park HW, Brenner C, PLoS Biol. 2007 Oct 2;5(10):e263. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=17914902 17914902] |
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
- | [[Category: Arrowsmith, C | + | [[Category: Arrowsmith, C H.]] |
[[Category: Bochkarev, A.]] | [[Category: Bochkarev, A.]] | ||
[[Category: Brenner, C.]] | [[Category: Brenner, C.]] | ||
- | [[Category: Edwards, A | + | [[Category: Edwards, A M.]] |
[[Category: Landry, R.]] | [[Category: Landry, R.]] | ||
[[Category: Nedyalkova, L.]] | [[Category: Nedyalkova, L.]] | ||
[[Category: Park, H.]] | [[Category: Park, H.]] | ||
- | [[Category: Rabeh, W | + | [[Category: Rabeh, W M.]] |
- | [[Category: SGC, Structural | + | [[Category: SGC, Structural Genomics Consortium.]] |
[[Category: Sundstrom, M.]] | [[Category: Sundstrom, M.]] | ||
[[Category: Tempel, W.]] | [[Category: Tempel, W.]] | ||
Line 45: | Line 45: | ||
[[Category: transferase]] | [[Category: transferase]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 18:41:58 2008'' |
Revision as of 16:42, 21 February 2008
|
Human nicotinamide riboside kinase 1 in complex with ADP
Overview
The eukaryotic nicotinamide riboside kinase (Nrk) pathway, which is induced in response to nerve damage and promotes replicative life span in yeast, converts nicotinamide riboside to nicotinamide adenine dinucleotide (NAD+) by phosphorylation and adenylylation. Crystal structures of human Nrk1 bound to nucleoside and nucleotide substrates and products revealed an enzyme structurally similar to Rossmann fold metabolite kinases and allowed the identification of active site residues, which were shown to be essential for human Nrk1 and Nrk2 activity in vivo. Although the structures account for the 500-fold discrimination between nicotinamide riboside and pyrimidine nucleosides, no enzyme feature was identified to recognize the distinctive carboxamide group of nicotinamide riboside. Indeed, nicotinic acid riboside is a specific substrate of human Nrk enzymes and is utilized in yeast in a novel biosynthetic pathway that depends on Nrk and NAD+ synthetase. Additionally, nicotinic acid riboside is utilized in vivo by Urh1, Pnp1, and Preiss-Handler salvage. Thus, crystal structures of Nrk1 led to the identification of new pathways to NAD+.
About this Structure
2QSY is a Single protein structure of sequence from Homo sapiens with , and as ligands. Full crystallographic information is available from OCA.
Reference
Nicotinamide riboside kinase structures reveal new pathways to NAD+., Tempel W, Rabeh WM, Bogan KL, Belenky P, Wojcik M, Seidle HF, Nedyalkova L, Yang T, Sauve AA, Park HW, Brenner C, PLoS Biol. 2007 Oct 2;5(10):e263. PMID:17914902
Page seeded by OCA on Thu Feb 21 18:41:58 2008
Categories: Homo sapiens | Single protein | Arrowsmith, C H. | Bochkarev, A. | Brenner, C. | Edwards, A M. | Landry, R. | Nedyalkova, L. | Park, H. | Rabeh, W M. | SGC, Structural Genomics Consortium. | Sundstrom, M. | Tempel, W. | Weigelt, J. | ADP | MG | UNX | Adp | Alternative splicing | Atp-binding | Nad biosynthesis | Nad+ | Nicotinamide riboside | Nicotinamide riboside kinase activity | Nicotinic acid riboside kinase activity | Non-protein kinase | Nrk1 | Nucleotide-binding | Pyridine nucleotide biosynthesis | Sgc | Structural genomics | Structural genomics consortium | Transferase